These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9056159)

  • 1. Competitive development of new ultrasound, X-ray and MR contrast media.
    Spinazzi A
    Eur J Radiol; 1996 Nov; 23 Suppl 1():S14-6. PubMed ID: 9056159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New non-ionic contrast: effects on the cardiovascular system.
    Pagny JY; Gaux JC
    Eur J Radiol; 1996 Nov; 23 Suppl 1():S2-5. PubMed ID: 9056156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations.
    Gallotti A; Uggeri F; Favilla A; Cabrini M; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S1-12. PubMed ID: 8020510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation.
    Vijayalakshmi K; Kunadian B; Wright RA; Hall JA; Stewart MJ; Davies A; Sutton A; de Belder MA
    Eur J Radiol; 2007 Feb; 61(2):342-50. PubMed ID: 17101256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro.
    Heinrich MC; Kuhlmann MK; Grgic A; Heckmann M; Kramann B; Uder M
    Radiology; 2005 Jun; 235(3):843-9. PubMed ID: 15845795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
    Chicaíza-Becerra LA; García-Molina M; Gamboa Ó
    Biomedica; 2012 Jun; 32(2):182-8. PubMed ID: 23242291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iomeprol: current and future profile of a radiocontrast agent.
    Katayama H; Spinazzi A; Fouillet X; Kirchin MA; Taroni P; Davies A
    Invest Radiol; 2001 Feb; 36(2):87-96. PubMed ID: 11224756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety profile of new non-ionic contrast media: renal tolerance.
    Stacul F; Thomsen HS
    Eur J Radiol; 1996 Nov; 23 Suppl 1():S6-9. PubMed ID: 9056157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iomeprol versus iopamidol in contrast-enhanced computed tomography of thoracic and abdominal organs.
    Valentini AL; Tartaglione T; Monti L; Marano P
    Eur J Radiol; 1994 May; 18 Suppl 1():S88-92. PubMed ID: 8020525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low-osmolality contrast media on red cell filterability.
    Imai H; Hiruma H; Kumazaki T; Uyesaka N
    Acta Radiol; 1993 May; 34(3):214-9. PubMed ID: 8489832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late reactions to a radiologic contrast media (Iopamidol-Bracco). Prospective study].
    Bartolucci F; Cecarini M; Gabrielli G; Abbiati R; Barberio M; Busilacchi P
    Radiol Med; 2000 Oct; 100(4):273-8. PubMed ID: 11155455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of iomeprol on rat hippocampal slice synaptic transmission: comparison with other X-ray contrast agents.
    Frigeni V; Samuelli G; Miragoli L; Grotti A; Lorusso V
    Invest Radiol; 2002 Apr; 37(4):222-31. PubMed ID: 11923645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility and safety profile of iomeprol.
    Rosati G
    Eur J Radiol; 1994 May; 18 Suppl 1():S120-4. PubMed ID: 8020514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty.
    Schräder R; Esch I; Ensslen R; Fach WA; Merle H; Scherer D; Sievert H; Spies HF; Zeplin HE
    J Am Coll Cardiol; 1999 Feb; 33(2):395-402. PubMed ID: 9973019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iohexol and iopamidol: second-generation nonionic radiographic contrast media.
    Kawada TK
    Drug Intell Clin Pharm; 1985; 19(7-8):525-9. PubMed ID: 3896713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with iomeprol in myelography and myelo-CT: clinical pharmacology and double-blind comparisons with iopamidol, iohexol, and iotrolan.
    Katayama H; Heneine N; van Gessel R; Taroni P; Spinazzi A
    Invest Radiol; 2001 Jan; 36(1):22-32. PubMed ID: 11176258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iomeprol vs iopamidol in intraarterial peripheral digital subtraction angiography.
    Dacoronias D; Minguzzi P; Ugolotti U; Dettori AG
    Angiology; 1992 Sep; 43(9):734-40. PubMed ID: 1514709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stability of iodinated contrast media in UV-laser irradiation and toxicity of the photoproducts].
    Grönewäller EF; Wahl HG; Kehlbach R; Rodemann HP; Claussen CD; Duda SH
    Rofo; 1998 Nov; 169(5):537-41. PubMed ID: 9849607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonionic contrast media iohexol and iomeprol decrease renal arterial tone: comparative studies on human and porcine isolated vascular segments.
    Uder M; Humke U; Pahl M; Jansen A; Utz J; Kramann B
    Invest Radiol; 2002 Aug; 37(8):440-7. PubMed ID: 12138360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of radiographic contrast media on the nitric oxide release from human arterial and venous endothelial cells on extracellular matrix.
    Franke RP; Fuhrmann R; Jung F
    Clin Hemorheol Microcirc; 2013; 55(1):95-100. PubMed ID: 23445626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.